News + Filings Transactions
|
Esposito Pamela
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/22/2023 | Replimune Group, Inc. | REPL | Sale | Common Stock | 18.6k | $20.01 | $372.2k | | 08/22/2023 |
| 08/22/2023 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 13.6k | $3.30 | $44.9k | | 08/22/2023 |
| 08/22/2023 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 5k | $15.50 | $77.5k | | 08/22/2023 |
| 08/11/2023 | Replimune Group, Inc. | REPL | Sale | Common Stock | 1.4k | $20.00 | $28k | | 08/11/2023 |
| 08/11/2023 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 1.4k | $3.30 | $4.6k | | 08/11/2023 |
| 07/10/2023 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 5k | $15.50 | $77.5k | | 07/10/2023 |
| 07/10/2023 | Replimune Group, Inc. | REPL | Sale | Common Stock | 17.9k | $21.63 | $387.7k | | 07/10/2023 |
| 07/10/2023 | Replimune Group, Inc. | REPL | Sale | Common Stock | 2.1k | $21.12 | $43.9k | | 07/10/2023 |
| 07/10/2023 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 15k | $3.30 | $49.5k | | 07/10/2023 |
| 05/16/2023 | Replimune Group, Inc. | REPL | Sale | Common Stock | 6k | $18.05 | $107.7k | | 05/16/2023 |
| 04/01/2023 | Replimune Group, Inc. | REPL | Grant | Common Stock | 40k | $0.00 | $0 | | 04/01/2023 |
| 04/01/2023 | Replimune Group, Inc. | REPL | Grant | Employee Stock Option (right to buy) | 60k | $17.66 | $1.1M | | 04/01/2023 |
| 12/09/2022 | Replimune Group, Inc. | REPL | Sale | Common Stock | 15k | $25.03 | $375.4k | | 12/09/2022 |
| 12/09/2022 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 15k | $1.01 | $15.2k | | 12/09/2022 |
| 06/15/2022 | Kymera Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 12k | $14.18 | $170.2k | | 06/15/2022 |
| 04/01/2022 | Replimune Group, Inc. | REPL | Grant | Employee Stock Option (right to buy) | 34.1k | $18.26 | $623.1k | | 04/01/2022 |
| 04/01/2022 | Replimune Group, Inc. | REPL | Grant | Common Stock | 22.8k | $0.00 | $0 | | 04/01/2022 |
| 08/05/2021 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 25.8k | $15.50 | $399.9k | | 08/04/2021 |
| 08/05/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 25.8k | $35.09 | $905.3k | | 08/04/2021 |
| 08/04/2021 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 4.2k | $15.50 | $65.1k | | 08/04/2021 |
| 08/04/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 4.2k | $35.00 | $147k | | 08/04/2021 |
| 07/15/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 4.6k | $33.37 | $153.5k | | 07/15/2021 |
| 07/15/2021 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 4.6k | $1.01 | $4.6k | | 07/15/2021 |
| 06/16/2021 | Kymera Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 20.1k | $49.10 | $985.1k | | 06/16/2021 |
| 04/01/2021 | Replimune Group, Inc. | REPL | Grant | Common Stock | 34.2k | $0.00 | $0 | | 04/01/2021 |
| 04/01/2021 | Replimune Group, Inc. | REPL | Grant | Employee Stock Option (right to buy) | 51.2k | $31.58 | $1.6M | | 04/01/2021 |
| 01/19/2021 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 5.7k | $1.01 | $5.8k | | 01/14/2021 |
| 01/19/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 600 | $43.24 | $25.9k | | 01/14/2021 |
| 01/19/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 5.1k | $42.38 | $217.3k | | 01/14/2021 |
| 01/19/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 600 | $43.24 | $25.9k | | 01/14/2021 |
| 01/19/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 5.1k | $42.38 | $217.3k | | 01/14/2021 |
| 01/19/2021 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 5.7k | $1.01 | $5.8k | | 01/14/2021 |
| 01/15/2021 | Replimune Group, Inc. | REPL | Exercise | Employee Stock Option (right to buy) | 29.3k | $1.01 | $29.6k | | 01/14/2021 |
| 01/15/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 29.3k | $43.58 | $1.3M | | 01/14/2021 |
| 01/15/2021 | Replimune Group, Inc. | REPL | Sale | Common Stock | 29.3k | $43.58 | $1.3M | | 01/14/2021 |
|
|